| AMNEAL PHARMACEUTICALS |
| USA |
| Gesundheit |
| US03168L1052 / A2JLMD |
| 2DT (Frankfurt) / AMRX (NASDAQ) |
| FRA:2DT, ETR:2DT, 2DT:GR, NASDAQ:AMRX |
| - |
| https://www.amneal.com/ |
|
Amneal Pharmaceuticals Inc. is a renowned entity in the pharmaceutical industry, known for its focus on the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The c..
>Volltext.. |
| 3883.11 Mio. EUR |
| 6029.09 Mio. EUR |
| 2486.53 Mio. EUR |
| 512.38 Mio. EUR |
| 5 Mio. EUR |
| 0.02 EUR |
| 2275.37 Mio. EUR |
| 199.92 Mio. EUR |
| 277.62 Mio. EUR |
| 0.27 |
| 3.89% |
| - |
| - |
| - |
| - |
| - |
| AMNEAL |
| 27.02.26 |
|
||||
|